NCT00479921View on ClinicalTrials.gov

Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in Europe

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2007

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

Trivalent influenza subunit vaccine

Trial Locations (2)

Unknown

Site 1, Tessenderlo

Site 2, Hamburg

All Listed Sponsors
lead

Solvay Pharmaceuticals

INDUSTRY

NCT00479921 - Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in Europe | Biotech Hunter | Biotech Hunter